GlassScriptPhysician profile
Michael T Mcenrue
NPI 1093349359
$1,456.00
in general payments reported to CMS, 2019-2025
16 companies · $172 in 2025
The $172 reported for 2025 was less than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $379 · 2022: $601 · 2023: $180 · 2024: $124 · 2025: $172.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $476.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $475.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $640.36 | 2021-2025 | Xtandi, Padcev |
| Abbvie INC. | $259.01 | 2021-2024 | |
| Coloplast Corp | $78.59 | 2021-2024 | Restorelle |
| Axonics, INC. | $65.47 | 2023-2024 | Axonics |
| Pfizer INC. | $64.96 | 2021-2025 | |
| Boston Scientific Corporation | $49.78 | 2024-2025 | Rezum Generator, Bulkamid |
| Urogen Pharma, INC. | $42.99 | 2022-2025 | |
| Myovant Sciences INC. | $42.22 | 2021 | |
| Allergan, INC. | $40.86 | 2022 | |
| Endo Pharmaceuticals INC. | $34.61 | 2022 | |
| Urovant Sciences INC | $32.08 | 2021-2022 | |
| 180 Medical, INC. | $26.85 | 2025 | |
| Accord Healthcare, INC. | $26.49 | 2023 | |
| Amgen INC. | $21.83 | 2021 | |
| Tolmar Pharmaceuticals, INC. | $16.12 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.78 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Mcenrue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.